跳至主要内容
临床试验/NL-OMON24550
NL-OMON24550暂停不适用

Double-blind randomized trial comparing efficacy, safety and tolerance between Levetiracetam monotherapy and Valproic acid monotherapy in children with newly diagnosed epilepsy.

Prof.dr. O.F. Brouwer0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
200

研究概览

简要总结

Weijenberg A, Callenbach PMC, Brouwer OF for the LEV-VPA study group. Investigator-initiated randomized controlled trials in children with epilepsy: Mission impossible? Epilepsia Open 2016;2:32-8

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Children of either sex from age 2 until (and including) age 15 years with weight between 13 and 60 kilograms;
  • 2. New but confident diagnosis of epilepsy made during the last year;
  • 3. According to the treating physician initiation of antiepileptic medication is indicated.

排除标准

  • 1. BMI >25;
  • 2. Treatable underlying cause of epilepsy (e.g. GLUT1-deficiency syndrome);

研究者

发起方
Prof.dr. O.F. Brouwer

相似试验